HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olivier Tredan Selected Research

Olivier Tredan Research Topics

Disease

33Breast Neoplasms (Breast Cancer)
11/2023 - 07/2009
31Neoplasms (Cancer)
01/2023 - 07/2009
7Ovarian Neoplasms (Ovarian Cancer)
03/2024 - 10/2011
4Ovarian Epithelial Carcinoma
01/2023 - 11/2019
4Carcinoma (Carcinomatosis)
01/2023 - 10/2011
4Neoplasm Metastasis (Metastasis)
01/2023 - 07/2011
3Lymphoma (Lymphomas)
01/2023 - 07/2009
3Fatigue
01/2023 - 10/2020
3Lymphopenia (Lymphocytopenia)
03/2013 - 07/2009
2Febrile Neutropenia
01/2023 - 04/2019
2Neutropenia
01/2023 - 04/2019
2Triple Negative Breast Neoplasms
01/2023 - 12/2021
2Obesity
01/2022 - 11/2013
1Sleep Initiation and Maintenance Disorders (Insomnia)
11/2023
1Amenorrhea
11/2023
1Chronic Obstructive Pulmonary Disease (COPD)
03/2023
1Lymphocele
01/2023
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2023
1Peritoneal Neoplasms
01/2023
1Weight Loss (Weight Reduction)
03/2022
1Genomic Instability
02/2022
1COVID-19
01/2022
1Body Weight (Weight, Body)
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Brain Neoplasms (Brain Tumor)
11/2021
1Disease Progression
11/2021
1Anus Neoplasms (Anal Cancer)
07/2021
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2021
1Endodermal Sinus Tumor (Endodermal Sinus Tumors)
01/2021
1Microsatellite Instability
01/2021
1Hemangiosarcoma (Angiosarcoma)
12/2020
1Pain (Aches)
10/2020
1Adenocarcinoma
05/2020
1Hypertension (High Blood Pressure)
03/2016

Drug/Important Bio-Agent (IBA)

7Hormones (Hormone)IBA
01/2023 - 07/2011
5Bevacizumab (Avastin)FDA Link
03/2024 - 10/2011
4PlatinumIBA
03/2024 - 11/2019
3Taxoids (Taxanes)IBA
01/2023 - 10/2011
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2023 - 04/2019
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020 - 10/2011
2olaparibIBA
03/2024 - 11/2019
2Immune Checkpoint InhibitorsIBA
02/2022 - 01/2018
2Paclitaxel (Taxol)FDA LinkGeneric
02/2022 - 11/2020
2VaccinesIBA
01/2022 - 05/2020
2Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021 - 11/2020
2EverolimusFDA Link
11/2021 - 01/2021
2MTOR InhibitorsIBA
01/2021 - 12/2011
2Estrogen ReceptorsIBA
06/2015 - 12/2011
2Estrogens (Estrogen)FDA Link
04/2015 - 02/2012
1durvalumabIBA
03/2024
1SolutionsIBA
05/2023
1ORALIT (ORS)IBA
01/2023
1Biosimilar PharmaceuticalsIBA
01/2023
1Filgrastim (Neupogen)FDA Link
01/2023
1erucylphosphocholineIBA
12/2022
1CoffeeFDA Link
10/2022
1TeaIBA
10/2022
1Biomarkers (Surrogate Marker)IBA
03/2022
1Carboplatin (JM8)FDA LinkGeneric
02/2022
1nintedanibIBA
02/2022
1COVID-19 VaccinesIBA
01/2022
1Trastuzumab (Herceptin)FDA Link
01/2022
1rucaparibIBA
12/2021
1Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2021
1Sorafenib (BAY 43-9006)FDA Link
11/2021
1ruxolitinibIBA
11/2021
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
06/2021
1Mechanistic Target of Rapamycin Complex 1IBA
01/2021
1pazopanibFDA Link
12/2020
13-acetylpyridine adenine dinucleotide (APAD)IBA
10/2020
1AntigensIBA
05/2020
1Tn antigenIBA
05/2020
1AntibodiesIBA
05/2020
1Complement System Proteins (Complement)IBA
05/2020
1GlycopeptidesIBA
05/2020
1CarbohydratesIBA
05/2020
1TamoxifenFDA LinkGeneric
01/2020
1abirateroneIBA
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1Androgen Receptors (Androgen Receptor)IBA
01/2018
1Adenosine (Adenocard)FDA LinkGeneric
01/2018
1beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
01/2018
1Adenosine Triphosphatases (ATPase)IBA
01/2018
1cadherin 5IBA
01/2017
1Phosphotransferases (Kinase)IBA
09/2015

Therapy/Procedure

24Drug Therapy (Chemotherapy)
03/2024 - 07/2009
21Therapeutics
11/2023 - 12/2011
4Adjuvant Chemotherapy
01/2022 - 05/2015
3Neoadjuvant Therapy
01/2023 - 12/2021
3Radiotherapy
07/2021 - 02/2018
2Cytoreduction Surgical Procedures
01/2023 - 01/2023
2Drug Tapering
01/2023 - 04/2019
2Palliative Care (Palliative Therapy)
12/2022 - 02/2015
1Polypharmacy
03/2023
1Blood Transfusion (Blood Transfusions)
01/2023
1Splenectomy
01/2023
1Caloric Restriction
03/2022
1Length of Stay
01/2022
1Precision Medicine
11/2021
1Cryosurgery
02/2018